載入...
Serum potassium in the PARADIGM‐HF trial
AIMS: The associations between potassium level and outcomes, the effect of sacubitril–valsartan on potassium level, and whether potassium level modified the effect of sacubitril–valsartan in patients with heart failure and a reduced ejection fraction were studied in PARADIGM‐HF. Several outcomes, in...
Na minha lista:
| 發表在: | Eur J Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7756204/ https://ncbi.nlm.nih.gov/pubmed/32809261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.1987 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|